Perfluorochemical augmented rhSOD delivery attenuates inflammation in the immature lung

Journal of Neonatal-Perinatal Medicine

Volumn 1, Issue 3, 2008, Pages 159-168

  Sarafidis, Kosmas ^a   Malone, Daniel J ^b   Zhu, Guangfa ^b,c   Kazzaz, Jeffrey A ^d   Davis, Jonathan M ^d,e   Shaffer, Thomas H ^b,f   Wolfson, Marla R ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d WINTHROP UNIVERSITY HOSPITAL   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

Antioxidants; Bronchopulmonary dysplasia; Lung inflammation; Oxidative stress; Perfluorochemical liquid

Indexed keywords

EID: 85013591298     PISSN: 19345798     EISSN: 18784429     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. E. Bancalari, N. Claure and I.R. Sosenko, Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition, Semin Neonatol 8 (2003), 63-71.
2. M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem 72 (1976), 248-254.
3. L.A. Brennan, R.H. Steinhorn, S. Wedgwood et al., Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase, Circ Res 92 (2003), 683-691.
4. L. Brunelli, E. Hamilton, J.M. Davis et al., Perfluorochemical liquids enhance delivery of superoxide dismutase to the lungs of juvenile rabbits, Pediatr Res 60 (2006), 65-70.
5. S.E. Chappell, M.R. Wolfson and T.H. Shaffer, A comparison of surfactant delivery with conventional mechanical ventilation and partial liquid ventilation in meconium aspiration injury, Respir Med 95 (2001), 612-617.
6. P.R. Chess, C.T. D’Angio, G.S. Pryhuber and W.M. Maniscalco, Pathogenesis of bronchopulmonary dysplasia, Semin Perinatol 30 (2006), 171-178.
7. J.D. Crapo, J.M. McCord and I. Fridovich, Preparation and assay of superoxide dismutases, Methods Enzymol 53 (1978), 382-393.
8. A.B. Cullen, C.A. Cox, S.J. Hipp, M.R. Wolfson and T.H. Shaffer, Intra-tracheal delivery strategy of gentamicin with partial liquid ventilation, Respir Med 93 (1999), 770-778.
9. J.M. Davis, W. Rosenfeld, A. Gonenne et al., The Protective Effects of Recombinant Human Cu/Zn Superoxide-Dismutase (SOD) on Lung Injury from Hyperoxia and Hyperventilation in Neonatal Piglets, Pediatric Research 29 (1991), A313.
10. J.M. Davis, W.N. Rosenfeld, S.E. Richter et al., Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome, Pediatrics 100 (1997), 24-30.
11. C.H. Fardy and M. Silverman, Antioxidants in neonatal lung disease, Arch Dis Child Fetal Neonatal Ed 73 (1995), F112-F117.
12. R. Foust, III, N.N. Tran, C. Cox et al., Liquid assisted ventilation: an alternative ventilatory strategy for acute meconium aspiration injury, Pediatr Pulmonol 21 (1996), 316-322.
13. L. Frank and I.R. Sosenko, Development of lung antioxidant enzyme system in late gestation: possible implications for the prematurely born infant, J Pediatr 110 (1987), 9-14.
14. L. Frank and I.R. Sosenko, Prenatal development of lung antioxidant enzymes in four species, J Pediatr 110 (1987), 106-110.
15. M.D. Henry, C.M. Rebello, M. Ikegami, A.H. Jobe, E.G. Langenback and J.M. Davis, Ultrasonic nebulized in comparison with instilled surfactant treatment of preterm lambs, Am J Respir Crit Care Med 154 (1996), 366-375.
16. M.J. Jeng, S.S. Yang, M.R. Wolfson and T.H. Shaffer, Perfluorochemical (PFC) combinations for acute lung injury: an in vitro and in vivo study in juvenile rabbits, Pediatr Res 53 (2003), 81-88.
17. A. Jobe, M. Ikegami, H. Jacobs and S. Jones, Surfactant and pulmonary blood flowdistributions following treatment of premature lambs with natural surfactant, J Clin Invest 73 (1984), 848-856.
18. B. Jonsson, K. Tullus, A. Brauner, Y. Lu and G. Noack, Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants, Arch Dis Child Fetal Neonatal Ed 77 (1997), F198-F201.
19. K. Kawamae, G. Pristine, D. Chiumello, L.N. Tremblay and A.S. Slutsky, Partial liquid ventilation decreases serum tumor necrosis factor-alpha concentrations in a rat acid aspiration lung injury model, Crit Care Med 28 (2000), 479-483.
20. J.P. Kinsella, T.A. Parker, J.M. Davis and S.H. Abman, Superoxide dismutase improves gas exchange and pulmonary hemodynamics in premature lambs, Am J Respir Crit Care Med 172 (2005), 745-759.
21. T. Koch, M. Ragaller, D. Haufe et al., Perfluorohexane attenuates proinflammatory and procoagulatory response of activated monocytes and alveolar macrophages, Anesthesiology 94 (2001), 101-109.
22. M.F. Krause, C. Jakel, J. Haberstroh, J. Schulte-Monting, J.U. Leititis and M. Orlowska-Volk, Alveolar recruitment promotes homogeneous surfactant distribution in a piglet model of lung injury, Pediatr Res 50 (2001), 34-43.
23. E.G. Langenback, J.M. Davis, C. Robbins, N. Sahgal, R.J. Perry and S.R. Simon, Improved pulmonary distribution of recombinant human Cu/Zn superoxide dismutase, using a modified ultrasonic nebulizer, Pediatr Pulmonol 27 (1999), 124-129.
24. U. Merz, B. Klosterhalfen, M. Hausler, M. Kellinghaus, T. Peschgens and H. Hornchen, Partial liquid ventilation reduces release of leukotriene B4 and interleukin-6 in bronchoalveolar lavage in surfactant-depleted newborn pigs, Pediatr Res 51 (2002), 183-189.
25. T.F. Miller, B. Milestone, R. Stern, T.H. Shaffer and M.R. Wolfson, Effects of perfluorochemical distribution and elimination dynamics on cardiopulmonary function, J Appl Physiol 90 (2001), 839-849.
26. J.D. Mrozek, K.M. Smith, D.R. Bing et al., Exogenous surfactant and partial liquid ventilation: physiologic and pathologic effects, Am J Respir Crit Care Med 156 (1997), 1058-1065.
27. U.K. Munshi, J.O. Niu, M.M. Siddiq and L.A. Parton, Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia, Pediatr Pulmonol 24 (1997), 331-336.
28. P. Oishi, A. Grobe, E. Benavidez et al., Inhaled nitric oxide inducedNOSinhibition and rebound pulmonary hypertension: a role for superoxide and peroxynitrite in the intact lamb, Am J Physiol Lung Cell Mol Physiol 290 (2006), L359-L366.
29. A.G. Philip, Oxygen plus pressure plus time: the etiology of bronchopulmonary dysplasia, Pediatrics 55 (1975), 44-50.
30. W.N. Rosenfeld, J.M. Davis, L. Parton et al., Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome, Pediatrics 97 (1996), 811-817.
31. A.T. Rotta, B. Gunnarsson, L.J. Hernan, B.P. Fuhrman and D.M. Steinhorn, Partial liquid ventilation with perflubron at tenuates in vivo oxidative damage to proteins and lipids, Crit Care Med 28 (2000), 202-208.
32. N. Sahgal, J.M. Davis, C. Robbins et al., Localization and activity of recombinant human CuZn superoxide dismutase after intratracheal administration, Am J Physiol 271 (1996), L230-L235.
33. C. Schierwagen, A.A. Bylung-Fellenjus and C. Lunberg, An improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity, J Pharmacol Meth 23 (1990), 174-186.
34. B.N. Shashikant, T.L. Miller, M.J. Jeng, J. Davis, T.H. Shaffer and M.R. Wolfson, Differential impact of perfluorochemical physical properties on the physiologic, histologic, and inflammatory profile in acute lung injury, Crit Care Med 33 (2005), 1096-1103.
35. B.N. Shashikant, T.L. Miller, R.W. Welch, A.L. Pilon, T.H. Shaffer and M.R. Wolfson, Dose response to rhCC10- augmented surfactant therapy in a lamb model of infant respiratory distress syndrome: physiological, inflammatory, and kinetic profiles, J Appl Physiol 99 (2005), 2204-2211.
36. T.M. Smith, D.M. Steinhorn, K. Thusu, B.P. Fuhrman and P. Dandona, A liquid perfluorochemical decreases the in vitro production of reactive oxygen species by alveolar macrophages, Crit Care Med 23 (1995), 1533-1539.
37. V.C. Smith, J.A Zupancic, M.C. McCormick et al., Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia, J Pediatr 144 (2004), 799-803.
38. V.C. Smith, J.A. Zupancic, M.C. McCormick et al., Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002, J Pediatr 146 (2005), 469-473.
39. A. Soler, M.R. Wolfson, N. Kechner, R. Foust and T.H. Shaffer, Comparison of natural surfactant and brief liquid ventilation rescue treatment in very immature lambs. Clinical and physiological correlates, Biol Neonate 69 (1996), 275-283.
40. D.M. Steinhorn, M.C. Papo, A.T. Rotta, A. Aljada, B.P. Fuhrman and P. Dandona, Liquid ventilation attenuates pulmonary oxidative damage, J Crit Care 14 (1999), 20-28.
41. R.H. Steinhorn, G. Albert, D.D. Swartz, J.A. Russell, C.R. Levine and J.M. Davis, Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension, Am J Respir Crit Care Med 164 (2001), 834-839.
42. M.J. Thomassen, L.T. Buhrow and H.P. Wiedemann, Perflubron decreases inflammatory cytokine production by human alveolar macrophages, Crit Care Med 25 (1997), 2045-2047.
43. M.R. Wolfson, J.S. Greenspan, K.S. Deoras, S.D. Rubenstein and T.H. Shaffer, Comparison of gas and liquid ventilation: clinical, physiological, and histological correlates, J Appl Physiol 72 (1992), 1024-1031.
44. M.R. Wolfson, J.S. Greenspan and T.H. Shaffer, Pulmonary administration of vasoactive substances by perfluorochemical ventilation, Pediatrics 97 (1996), 449-455.
45. M.R. Wolfson, N.E. Kechner, R.F. Roache et al., Perfluorochemical rescue after surfactant treatment: effect of perflubron dose and ventilatory frequency, J Appl Physiol 84 (1998), 624-640.